Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
ID07236021

Promoting Emotion Regulation in Patients Living With Chronic Cancer: A Pilot Study to Assess Feasibility, Acceptability, and Tolerability (e-Motion Project)

Led by Université Libre de Bruxelles · Updated on 2025-11-21

30

Participants Needed

2

Research Sites

N/A

Total Duration

On this page

Sponsors

U

Université Libre de Bruxelles

Lead Sponsor

C

Centre de Psycho-Oncologie (CPO)

Collaborating Sponsor

AI-Summary

What this Trial Is About

Researchers are evaluating two types of emotion regulation interventions designed to support adults living with chronic cancer, recently diagnosed within the past 12 months. This pilot study aims to assess the feasibility, acceptability, and tolerability of these interventions, as well as their preliminary effects on psychological symptoms like anxiety, depression, worry, and fear of cancer recurrence. The study is led by the Université Libre de Bruxelles and focuses on patients with various metastatic cancers and symptomatic multiple myeloma. The study includes two intervention groups. The first group receives a Guided Self-Help intervention involving eight weekly self-administered modules with breathing, relaxation, hypnosis, and positive psychology techniques, supported by weekly 15-minute psychologist calls. The second group receives the same content but delivered in eight weekly 2-hour group sessions via videoconference, alongside access to podcasts and home exercises for additional peer and therapist support. Each group consists of 5 patients, and the second group begins enrollment after the first completes their assessments. Participants are assessed before the intervention, weekly during the 12-week intervention with ecological momentary assessments of emotions, and 15 weeks after starting. Assessments include psychological symptom questionnaires and satisfaction surveys. Researchers track recruitment, retention, adherence to sessions and exercises, data completeness, participant satisfaction, emotional impact, and dropout rates. A semi-structured interview gathers qualitative feedback on intervention tolerability and acceptability. The total study duration per participant is about 15 weeks.

CONDITIONS

Brief Title

e-Motion : Promoting Emotion Regulation in Chronic Cancer

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Adults aged 18 or older
  • Diagnosed with chronic cancer (various metastatic cancers or symptomatic multiple myeloma) within the past 12 months
  • Completed at least one active cancer treatment session such as chemotherapy, surgery, radiotherapy, immunotherapy, or targeted therapy
Not Eligible

You will not qualify if you...

  • Life expectancy less than one year
  • Received more than the allowed number of treatment lines depending on cancer type
  • Diagnosed with oligometastatic cancer
  • Under 18 years of age
  • Not fluent in French
  • Unable to follow an online intervention
  • Severe cognitive impairment or severe and/or acute psychiatric disorder

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person or remote)

Baseline Assessment

Duration - 1 week

Participants complete self-reported questionnaires and a 7-day ecological momentary assessment on emotions before starting the intervention.

1 baseline visit (in-person or remote)

Treatment

Duration - 12 weeks

Participants receive either the Guided Self-Help Intervention with weekly psychologist calls or the Group and Guided Self-Help Intervention with weekly group videoconference sessions and access to self-help materials.

Weekly visits or calls for up to 12 weeks

Post-Intervention Assessment

Duration - 3 weeks

After completing the intervention, participants complete self-reported questionnaires, a 7-day ecological momentary assessment, a semi-structured interview on intervention tolerability and acceptability, and a satisfaction questionnaire.

1 follow-up visit (in-person or remote)

Trial Site Locations

Total: 2 locations

1

Institut Jules Bordet, Hôpital universitaire de Bruxelles

Brussels, Anderlecht, Belgium, 1070

Not Yet Recruiting

2

H.U.B Institut Jules Bordet

Brussels, Brussels Capital, Belgium, 1070

Actively Recruiting

Loading map...

Research Team

F

Florence Lewis, PhD

I

Isabelle Merckaert, Professor

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NON_RANDOMIZED

Model

PARALLEL

Primary Purpose

SUPPORTIVE_CARE

Number of Arms

2

Similar Trials

A Phase 1 Study of KTX-1001, an Oral, Selective MMSET Inhibi...

Multiple Myeloma

Actively Recruiting

22 locations

A Phase 1 / 2, Open-Label Study of REC-1245 in Participants ...

Unresectable

Actively Recruiting

6 locations

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here